Gain Therapeutics (GANX) Financials: Revenue & Earnings

GANX price $1.17 0.00 0.00%

Ticker
GANX
Price
$1.17
Change
0.00 0.00%
Market cap ?
$49.91M
P/E ?
-2.52
Forward P/E ?
3.66
Dividend yield ?
0.00%
Beta ?
0.19
Sector
Healthcare
Industry
Biotechnology

Financials

20182019202020212022202320242025
2060941301288811649941401085518000

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed proteins. Subsequently…

Fair value

GANX fair value $12.51. Price $1.17. Price is 91% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare GANX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.13—33.33K
2026-08-11-0.11-0.14—33.33K
2026-05-11-0.13-0.13—33.33K
2026-03-26-0.11-0.14—25.00K
2025-11-12-0.15-0.15——
2025-08-12-0.19-0.17——
2025-05-14-0.16-0.16—25.00K
2025-03-27-0.11-0.18——
2024-11-14-0.17-0.23—10.00K
2024-08-08-0.42-0.31—100.00K
2024-05-14-0.22-0.30—30.00K
2024-03-26-0.29-0.3264.80K320.00K
2023-11-14-0.37-0.47—320.00K
2023-08-10-0.62-0.33—1.01M
2023-05-12-0.43-0.4055.18K10.00K
2023-03-23-0.39-0.37140.11K10.00K
2022-11-10-0.38-0.46—51.50K
2022-08-08-0.43-0.3595.10K31.67K
2022-05-16-0.28-0.3445.01K39.00K
2022-03-24-0.25-0.4936.34K51.60K
2021-11-12-0.39-0.3427.34K13.62K
2021-08-11-0.30-0.3189.17K84.25K
2021-05-10-0.50-0.215.27K4.97K
2021-03-22-0.30—6.70K—
2020-12-31-0.15—9.14K—
2020-06-30-0.20—6.37K—
2020-03-31-0.22—6.67K—
2019-12-31-0.32———
2019-09-30-0.11—10.32K—
2019-06-30-0.11—10.32K—
2019-03-31-0.11—10.32K—
2018-09-30-0.06—5.15K—
2018-06-30-0.06—5.15K—
2018-03-31-0.06—5.15K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-15GOLDSTEIN DOV A MDBuy25.00K$1.6842.00K
2026-07-15Nicaise ClaudeBuy25.00K$1.6842.00K
2026-07-15Islam KhalidBuy25.00K$1.6842.00K
2026-07-15Melincoff Gwen ABuy25.00K$1.6842.00K
2026-07-15Riley Jeffrey ScottBuy25.00K$1.6842.00K
2026-07-15HASLER HANS PETERBuy25.00K$1.6842.00K
2026-03-24Mack GeneBuy200.00K$1.86372.00K
2026-03-24Fuggetta GianlucaBuy50.00K$1.8693.00K
2025-06-24Islam KhalidBuy15.00K$1.7926.85K
2025-06-24Nicaise ClaudeBuy15.00K$1.7926.85K
2025-06-24Riley Jeffrey ScottBuy15.00K$1.7926.85K
2025-06-24RICHMAN ERIC IBuy15.00K$1.7926.85K
2025-06-24HASLER HANS PETERBuy15.00K$1.7926.85K
2025-06-24GOLDSTEIN DOV A MDBuy15.00K$1.7926.85K
2025-06-24Melincoff Gwen ABuy15.00K$1.7926.85K
2025-03-20Fuggetta GianlucaBuy50.00K$2.29114.50K
2025-03-20Mack GeneBuy200.00K$2.29458.00K
2025-01-06Mack GeneBuy271.32K$2.44662.03K
2024-08-09Mack GeneBuy14.40K$1.0114.54K
2024-08-09Islam KhalidBuy50.00K$1.0049.94K
2024-07-01RICHMAN ERIC IBuy12.00K$1.2114.52K
2024-07-01RICHMAN ERIC IBuy5.00K$1.236.15K
2024-06-24Islam KhalidBuy15.00K$1.2919.35K
2024-06-24Melincoff Gwen ABuy15.00K$1.2919.35K
2024-06-24HASLER HANS PETERBuy15.00K$1.2919.35K
2024-06-24Nicaise ClaudeBuy15.00K$1.2919.35K
2024-06-24RICHMAN ERIC IBuy15.00K$1.2919.35K
2024-06-24GOLDSTEIN DOV A MDBuy15.00K$1.2919.35K
2024-06-24Riley Jeffrey ScottBuy15.00K$1.2919.35K
2024-04-08Mack GeneBuy200.00K$3.56712.00K
2024-04-05Mack GeneOther0——
2024-03-28Riley Jeffrey ScottBuy30.00K$3.86115.77K
2024-03-26Alder MatthiasSell18.75K——
2024-03-26Alder MatthiasBuy637——
2024-03-26Alder MatthiasBuy825——
2024-03-26Alder MatthiasBuy18.75K——
2024-03-26Alder MatthiasSell6.08K$4.0624.71K
2024-03-26Alder MatthiasSell825——
2024-03-26Alder MatthiasSell637——
2024-03-21Fuggetta GianlucaBuy50.00K$4.37218.50K
2024-03-21Alder MatthiasBuy370.00K$4.371.62M
2023-12-21Alder MatthiasSell206$2.46507
2023-12-20Alder MatthiasSell637——
2023-12-20Alder MatthiasBuy637——
2023-12-07Alder MatthiasSell1.82K$2.504.55K
2023-10-01Alder MatthiasSell825——
2023-10-01Alder MatthiasBuy825——
2023-09-20RICHMAN ERIC IBuy54.90K——
2023-09-20RICHMAN ERIC ISell54.90K——
2023-09-20Alder MatthiasSell2.55K——
2023-09-20Alder MatthiasBuy2.55K——
2023-07-01Alder MatthiasSell3.30K——
2023-07-01Alder MatthiasBuy3.30K——
2023-06-23Islam KhalidBuy10.50K$4.5047.25K
2023-06-23Riley Jeffrey ScottBuy10.50K$4.5047.25K
2023-06-23GOLDSTEIN DOV A MDBuy10.50K$4.5047.25K
2023-06-23Melincoff Gwen ABuy10.50K$4.5047.25K
2023-06-23Nicaise ClaudeBuy10.50K$4.5047.25K
2023-06-23HASLER HANS PETERBuy10.50K$4.5047.25K
2023-04-10Ballantyne Charles EvanBuy100.00K$4.79479.00K
2023-04-10Ballantyne Charles EvanBuy50.00K——
2023-04-10Ballantyne Charles EvanOther0——
2023-03-23Calabrese SalvatoreBuy50.00K$4.84242.00K
2023-03-23Calabrese SalvatoreBuy25.00K——
2023-03-23Fuggetta GianlucaBuy15.00K$4.8472.60K
2023-03-23Alder MatthiasBuy150.00K$4.84726.00K
2023-03-23Alder MatthiasBuy75.00K——
2022-12-12Fuggetta GianlucaSell10.00K$3.4734.70K
2022-09-20RICHMAN ERIC IBuy329.40K$3.501.15M
2022-09-20RICHMAN ERIC IBuy54.90K——
2022-09-20Islam KhalidBuy10.50K$3.5036.75K
2022-09-20Melincoff Gwen ABuy10.50K$3.5036.75K
2022-09-20Nicaise ClaudeBuy10.50K$3.5036.75K
2022-07-15Calabrese SalvatoreBuy9.90K——
2022-07-15Alder MatthiasBuy79.20K——
2022-05-25RICHMAN ERIC IBuy2.48K$2.586.40K
2022-05-19RICHMAN ERIC IBuy9.26K$2.8326.19K
2022-05-19RICHMAN ERIC IBuy4.00K$2.7110.84K
2022-05-19Calabrese SalvatoreBuy3.00K$2.708.10K
2022-05-19Calabrese SalvatoreBuy3.00K$8,100.0024.30M
2021-12-23Alder MatthiasBuy200.00K$5.861.17M
2021-12-23Alder MatthiasOther0——
2021-08-16RICHMAN ERIC IBuy4.92K$7.8738.72K
2021-08-16RICHMAN ERIC IBuy4.92K$7.8738.72K
2021-03-17RICHMAN ERIC ISell26.42K$3.3889.31K
2021-03-17Bellotto ManoloSell123.31K$3.37415.55K
2021-03-17Calabrese SalvatoreSell83.67K$3.37281.98K
2021-03-17Riley Jeffrey ScottSell10.00K$3.3733.70K
2021-03-17HASLER HANS PETERSell10.00K$3.3733.70K
2021-03-17Melincoff Gwen ASell10.00K$3.3733.70K
2021-03-17Nicaise ClaudeSell10.00K$3.3733.70K
2021-03-17Islam KhalidOther0——
2021-03-17Islam KhalidSell25.00K$3.3784.25K
2021-03-17RICHMAN ERIC ISell0——
2021-03-17GOLDSTEIN DOV A MDSell10.00K$3.3733.70K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 54, holders +8 vs prior quarter. Ownership 20.20%.

HolderSharesChangeChange %Value
MARSHALL WACE, LLP1.92M153.76K+8.69%3.90M
POTOMAC CAPITAL MANAGEMENT, INC.946.40K-62.20K-6.17%1.92M
GSA CAPITAL PARTNERS LLP632.13K319.66K+102.30%1.28M
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.568.64K00.00%1.15M
DME CAPITAL MANAGEMENT, LP566.13K00.00%1.15M
JONES FINANCIAL COMPANIES LLLP608.59K-23.02K-3.65%1.07M
VANGUARD CAPITAL MANAGEMENT LLC480.27K80.38K+20.10%974.95K
GEODE CAPITAL MANAGEMENT, LLC453.50K6.16K+1.38%921.37K
BLACKROCK, INC.274.96K49.91K+22.18%558.16K
VANGUARD FIDUCIARY TRUST CO231.53K1.55K+0.68%470.01K
UBS GROUP AG215.01K-5.48K-2.48%436.48K
STRATOS WEALTH PARTNERS, LTD.200.00K68.38K+51.95%406.00K
CRESSET ASSET MANAGEMENT, LLC160.00K00.00%324.80K
STATE STREET CORP157.54K00.00%319.80K
CITADEL ADVISORS LLC154.52K140.02K+965.68%313.68K
SQUAREPOINT OPS LLC136.36K136.36KNew276.81K
MORGAN STANLEY125.97K-13.68K-9.80%255.72K
LPL FINANCIAL LLC117.25K13.00K+12.47%238.02K
NORTHERN TRUST CORP97.01K-16.98K-14.90%196.94K
SUSQUEHANNA INTERNATIONAL GROUP, LLP78.21K78.21KNew158.76K
COMMONWEALTH EQUITY SERVICES, LLC58.46K28.75K+96.80%118.67K
JANE STREET GROUP, LLC55.63K17.03K+44.11%112.92K
XTX TOPCO LTD55.29K55.29KNew112.25K
JANE STREET GROUP, LLC41.60K3.00K+7.77%84.45K
CITADEL ADVISORS LLC40.70K26.20K+180.69%82.62K

Earnings and financials

Gain Therapeutics, Inc. (GANX) trades at $1.17, with a market cap of $49.91M and a trailing P/E of -2.52. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
2060941301288811649941401085518000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Gain Therapeutics (GANX) Financials: Revenue & Earnings

GANX$1.170.00 0.00%

$49.91M

Market Cap

-2.52

P/E

3.66

Forward P/E

—

Score

Price History